
Intuitive Surgical, Inc.
- Jurisdiction
United States - LEI
54930052SRG011710797 - ISIN
US46120E6023 (ISRG )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€194.14 98.3% overvalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
7
/ 7
Profile
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€7.80B - Gross margin
66.6% - EBIT
€2.25B - EBIT margin
28.8% - Net income
€2.22B - Net margin
28.5%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Ladd Amy L | N/A |
|
|
|
|
GUTHART GARY S | Executive Chair of the Board o |
|
|
|
|
GUTHART GARY S | Executive Chair of the Board o |
|
|
|
|
Curet Myriam | EVP & Chief Medical Officer |
|
|
|
|
Congress transactions
Name | Transaction date | Value |
---|---|---|
Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Lisa McClain | August 13, 2025 | $1.00K–$15.00K |
Jefferson Shreve | June 22, 2025 | $15.00K–$50.00K |
Jefferson Shreve | June 22, 2025 | $15.00K–$50.00K |
Josh Gottheimer | May 14, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
James Anderson |
|
|
|
Sell |
Peter Brown |
|
|
|
Buy |
Ray Dalio |
|
|
|
Sell |
Earnings Calls
Latest earnings call: April 18, 2024 (Q1 2024)